2nd Quarter - Report

AMERICAN ASSOCIATION OF BLOOD BANKS, DBA ASSOCIATION FOR THE ADVANCEMENT OF BLOOD & BIOTHERAPIES for AMERICAN ASSOCIATION OF BLOOD BANKS, DBA ASSOCIATION FOR THE ADVANCEMENT OF BLOO

Firm
Client
Income
—
Expenses
$35,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Budget/Appropriations BUD

Appropriations for blood safety surveillance program at the Centers for Disease Control and Prevention

LobbyistCovered position, as disclosed
CARYL AUSLANDER —
THERESA LAUERHASS WIEGMANN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Medical/Disease Research/Clinical Labs MED

Biomedical research funding at the National Heart, Lung and Blood Institute

LobbyistCovered position, as disclosed
CARYL AUSLANDER —
THERESA LAUERHASS WIEGMANN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Disaster Planning/Emergencies DIS

Disaster preparedness for the blood supply.

LobbyistCovered position, as disclosed
THERESA LAUERHASS WIEGMANN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Health Issues HCR

Blood Safety Issues Blood Safety Initiatives in reauthorization of the President's Emergency Plan for AIDS Relief (HR5501, S2731)

LobbyistCovered position, as disclosed
CARYL AUSLANDER —
THERESA LAUERHASS WIEGMANN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 5501 (110th)

Medicare/Medicaid MMM

Medicare reimbursement for blood, transfusion medicine and cellular therapies.

LobbyistCovered position, as disclosed
THERESA LAUERHASS WIEGMANN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.